// App-Quantinova.ai

1382 : Management of Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Novel Therapies in Routine Clinical Practice in Germany

Researchers

Presenter

  • H. Tilman Steinmetz

Principal Investigators

  • Moushmi Singh

  • Joseph Milce

  • Mohamad Haidar

  • Achim Rieth

  • Andrea Lebioda

Medical Centers

  • Pioh Hematology and Oncology, Cologne, Germany

  • Amgen, Ltd., Uxbridge, United Kingdom

  • Kantar,Paris,France

  • Amgen GmbH, Munich, Germany

Locations

  • Germany

  • United Kingdom

  • France

Companies

  • Amgen GmbH

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved